2026 presidential actions with healthcare-supply-chain implications — pharma tariffs, MFN drug pricing, DPA invocations
BLUF: Tracking 2026 presidential executive orders with direct healthcare supply-chain implications — pharma tariffs, MFN drug pricing, DPA invocations, and trade policy shifts affecting medical product sourcing and distribution.